A2 Adenosine Receptor-mediated Cardioprotection Against Reperfusion Injury in Rat Hearts Is Associated With Autophagy Downregulation

Journal of Cardiovascular Pharmacology

Volumn 66, Issue 1, 2015, Pages 25-34

  Ke, Jianjuan ^a   Yao, Bo ^a   Li, Tao ^b   Cui, Shanshan ^a   Ding, Huang ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

adenosine; autophagy; Bcl 2; Beclin 1; MIRI

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR AGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; BAY 60 6583; BECLIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3; PROTEIN BCL 2; TROPONIN I; UNCLASSIFIED DRUG; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BLOOD GAS ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL CORONARY OCCLUSION; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART MITOCHONDRION; HEART PROTECTION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; AUTOPHAGY; DOWN-REGULATION; MALE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADENOSINE A2;

EID: 84937694851     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000239     Document Type: Article

References (46)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135.
2. Ovize M, Baxter GF, Di Lisa F, et al; Working Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010;87:406-423.
3. Kin H, Zatta AJ, Lofye MT, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res. 2005;67:124-133.
4. Philipp S, Yang XM, Cui L, et al. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res. 2006;70:308-314.
5. Sachdeva S, Gupta M. Adenosine and its receptors as therapeutic targets: an overview. Saudi Pharm J. 2013;21:245-253.
6. Boucher M, Pesant S, Falcao S, et al. Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway. J Cardiovasc Pharmacol. 2004;43:416-422.
7. Visser SS, Theron AJ, Ramafi G, et al. Apparent involvement of the A (2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils. Biochem Pharmacol. 2000;60:993-999.
8. Sullivan GW, Rieger JM, Scheld WM, et al. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol. 2001;132:1017-1026.
9. Eltzschig HK, Bonney SK, Eckle T. Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med. 2013;19:345-354.
10. Eckle T, Hartmann K, Bonney S, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med. 2012;18:774-782.
11. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem. 2006;281:29776-29787.
12. Cheng BC, Huang HS, Chao CM, et al. Hypothermia may attenuate ischemia/reperfusion-induced cardiomyocyte death by reducing autophagy. Int J Cardiol. 2013;168:2064-2069.
13. Meijer AJ, Codogno P. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol. 2004;36:2445-2462.
14. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci. 2006;119:259-270.
15. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100:914-922.
16. Schindler CK, Shinoda S, Simon RP, et al. Subcellular distribution of Bcl-2 family proteins and 14-3-3 within the hippocampus during seizureinduced neuronal death in the rat. Neurosci Lett. 2004;356:163-166.
17. Maiuri MC, Le Toumelin G, Criollo A, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007;26:2527-2539.
18. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672-676.
19. Erlich S, Mizrachy L, Segev O, et al. Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy. 2007;3:561-568.
20. Noh HS, Shin IW, Ha JH, et al. Propofol protects the autophagic cell death induced by the ischemia/reperfusion injury in rats. Mol Cells. 2010; 30:455-460.
21. Ma X, Liu H, Foyil SR, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation. 2012;125:3170-3181.
22. Kilpatrick EL, Narayan P, Mentzer RM Jr, et al. Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization. Am J Physiol Heart Circ Physiol. 2002;282: H1035-H1040.
23. Chandrasekera PC, McIntosh VJ, Cao FX, et al. Differential effects of adenosine A2a and A2b receptors on cardiac contractility. Am J Physiol Heart Circ Physiol. 2010;299:H2082-H2089.
24. Hussain T, Linden J, Mustafa SJ. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE. J Pharmacol Exp Ther. 1996;276:284-288.
25. Olanrewaju HA, Qin W, Feoktistov I, et al. Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2000;279:H650-H656.
26. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 1991;84:341-349.
27. Hein TW, Belardinelli I, Kuo L. Adenosine A2A receptors mediate coronary microvascular dilation to adenosine:role of nitric oxide and atpsensitive potassium channels. J Phamacol Exp Ther. 1999;291:655-664.
28. Olanrewaju HA, Mustafa SJ. Adenosine A2A and A2B receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol. 2000;35:171-177.
29. El-Gowelli HM, El-Gowilly SM, Elsalakawy LK, et al. Nitric oxide synthase/K+ channel cascade triggers the adenosine A2B receptorsensitive renal vasodilation in female rats. Eur J Pharmacol. 2013;702: 116-125.
30. Yang Z, Day YJ, Toufektsian MC, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006;114:2056-2064.
31. Rork TH, Wallace KL, Kennedy DP, et al. Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. Am J Physiol Heart Circ Physiol. 2008;295:H1825-H1833.
32. Glover DK, Riou LM, Ruiz M, et al. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. Am J Physiol Heart Circ Physiol. 2005;288:H1851-H1858.
33. Headrick JP, Lasley RD. Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol. 2009;193:189-214.
34. Zhan E, McIntosh VJ, Lasley RD. Adenosine A(2)A and A(2)B receptors are both required for adenosine A(1) receptor-mediated cardioprotection. Am J Physiol Heart Circ Physiol. 2011;301:H1183-H1189.
35. Xi J, McIntosh R, Shen X, et al. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol. 2009;47:684-690.
36. Eckle T, Krahn T, Grenz A, et al. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation. 2007;115: 1581-1590.
37. Methner C, Schmidt K, Cohen MV, et al. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol. 2010;299:H1262-H1264.
38. Gustafsson AB, Gottlieb RA. Eat your heart out: role of autophagy in myocardial ischemia/reperfusion. Autophagy. 2008;4:416-421.
39. Wang ZV, Ferdous A, Hill JA. Cardiomyocyte autophagy: metabolic profit and loss. Heart Fail Rev. 2013;18:585-594.
40. Boya P, González-Polo RA, Casares N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25:1025-1040.
41. Zhao ZQ, Budde JM, Morris C, et al. Adenosine attenuates reperfusioninduced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol. 2001;33:57-68.
42. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122:927-939.
43. Tannous P, Zhu H, Nemchenko A, et al. Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation. 2008; 117:3070-3078.
44. Colecchia D, Strambi A, Sanzone S, et al. MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins. Autophagy. 2012;8:1724-1740.
45. Porrello ER, Delbridge LM. Cardiomyocyte autophagy is regulated by angiotensin II type 1 and type 2 receptors. Autophagy. 2009;5:1215-1216.
46. Wong A, Grubb DR, Cooley N, et al. Regulation of autophagy in cardiomyocytes by ins(1,4,5)P(3) and IP(3)-receptors. J Mol Cell Cardiol. 2013;54:19-24.